Oncogene alterations in primary, recurrent, and metastatic human bone tumors

Journal of Cellular Biochemistry

Volumn 63, Issue 1, 1996, Pages 37-50

  Pompetti, Franca ^b,e   Rizzo, Paola ^a   Simon, Richard M ^c   Freidlin, Boris ^d   Mew, Daphne J ^c   Pass, Harvey I ^c   Picci, Piero ^e   Levine, Arthur S ^b   Carbone, Michele ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d EMMES CORPORATION   (United States)

^e RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

chondrosarcoma; GCT; oncogene alterations; osteosarcoma

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CHONDROSARCOMA; GENE MUTATION; GIANT CELL TUMOR; HUMAN; HUMAN TISSUE; METASTASIS POTENTIAL; ONCOGENE C FOS; ONCOGENE C MYB; ONCOGENE C MYC; OSTEOSARCOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029782691     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199610)63:1<37::AID-JCB3>3.0.CO;2-0     Document Type: Article

References (39)

1. Baldini N, Scotlandi K, Barbanti-Brodano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, Serra M (1995): Expression of P-glycoprotein in high grade osteosarcomas in relation to clinical outcome. N Engl J Med 333:1380-1385.
2. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea R (1992): DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 36:988-993.
3. Berns EMJ, Klijn JGM, van Putten WLJ, van Staveren IL, Portengen H (1992): c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 52:1107-1113.
4. Bode U, Levine AS (1982): The biology and management of osteosarcoma. In: Levine AS (ed): "Cancer in the Young." New York: Masson Publishing USA Inc., pp. 575-614.
5. Bos JL (1989): Ras oncogenes in human cancer: A review. Cancer Res 49:4682-4689.
6. Brennan J, O'Connor T, Makuch RW, Simmons AM, Russell E, Linnoila RI, Phelps RM, Gadzar AF, Ihde DC, Johnson BE (1991): Myc family DNA amplification in 107 tumors and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res 51:1708-1712.
7. Cance WG, Brennan MF, Dudas ME, Huang C-M, Cordon-Cardo C (1990): Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457-1462.
8. Carbone M, Lewis AM, Jr., Matthews BJ, Levine AS, Dixon K (1989): SV40 small t antigen mutants induce true histiocytic lymphomas in hamsters. Cancer Res 49:1565-1571.
9. Carbone M, Levine AS (1990): Oncogenes, antioncogenes, and the regulation of cell growth. TEM 1:248-253.
10. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJY, Levine AS, Procopio A (1994): SV40-like sequences in human pleural mesothelioma. Oncogene 9:1781-1790.
11. Carbone M, Rizzo P, Pass HI (1995): Association of simian virus 40 with rodent and human mesotheliomas. In: Barbanti Brodano G, Bendinelli M, Friedman H (eds): "DNA Tumor Viruses: Oncogenic Mechanisms." New York and London: Plenum Press, pp 75-90.
12. Carbone M, Rizzo P, Procopio A, Giuliano M, Pass HI, Gebhardt MC, Mangham C, Hansen M, Malkin DF, Bushart G, Pompetti F, Picci P, Levine AS, Bergsagel JD, Garcea R: SV40-like sequences in human bone tumors. Oncogene (in press).
13. Cicala C, Pompetti F, Nguyen P, Dixon K, Levine AS, Carbone M (1992): SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B-lymphocytes in vivo. Virology 190:475-479.
14. Cicala C, Pompetti F, Carbone M (1993): SV40 induces mesotheliomas in hamsters. Am J Pathol 142:1524-1533.
15. De Mattei M, Martini F, Corallini A, Gerosa M, Scotland K, Carinci P, Barbanti-Brodano G, Tognon M (1995): High incidence of BK virus large T antigen coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer 61:756-760.
16. Diamandopoulous GT (1972): Leukemia, lymphoma, and osteosarcoma induced in Syrian golden hamster by SV40. Science 176:173-175.
17. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DJ, Jones PA, Cote RJ (1994): Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259-1264.
18. Fan S, El-Deiry WS, Bae I, Freeman J, Bhatia K, Fornace AJ, Jr, Magrath I, Kohn KW, O'Connor PM (1994): p53 mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res 54:5824-5830.
19. Fearon ER, Vogelstein B (1990): A genetic model for colorectal tumorigenesis. Cell 61:759-767.
20. Friend SH, Bernards R, Rogeji S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986): A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643-646.
21. Frost JA, Alberts AS, Sontag E, Guan K, Mumby MC, Feramisco JR (1994): Simian virus 40 small t antigen cooperates with mitogen activated kinases to stimulate AP-1 activity. Mol Cell Biol 14:6244-6252.
22. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994): Mutations in the p53 tumor suppressor gene; cluses to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878.
23. Harbour JW, Lai S-L, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ (1988): Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353-357.
24. Loewe SW, Ruley EH, Jacks T, Housman DE (1993): p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
25. Masuda H, Miller C, Koeffler HP, Battifora H, Cline MJ (1987): Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci USA 84:7716-7719.
26. Miller CW, Abdulkarim A, Tsay C, Slamon D, Ishizaki K, Toguchida J, Yamamuro T, Lampkin B, Koeffler HP (1990): Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res 50:7950-7954.
27. Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK (1990): Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87:5863-5867.
28. Paterson MC, Dietrich KD, Danyluk J, Paterson AHG, Lees AW, Jamil N, Hanson J, Jenkins H, Krause BE, McBlain WA, Slamon DJ, Fourney RM (1991): Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res 51:556-567.
29. Ray FA (1995): Simian virus 40 large T antigen induces chromosome damage that precedes and coincides with complete neoplastic transformation. In: Barbanti Brodano G, Bendinelli M, Friedman H (eds): "DNA Tumor Viruses: Oncogenic Mechanisms." New York and London: Plenum Press, pp 15-26.
30. Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, May P (1989): Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene 4:1483-1488.
31. Ruther U, Garber C, Komitowski D, Muller R, Wagner EF (1987): Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature 325:412-416.
32. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning, second edition." Cold Spring, NY: Cold Spring Harbor Laboratory Press, Vol 1. pp 6.2-6.62.
33. Toguchida J, Ishizaki K, Sasaki MS, Ikenaga M, Sugimoto M, Kotoura Y, Yamamuro T (1988): Chromosomal reorganization for the expression of recessive mutation of retincblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48:3939-3943.
34. Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrere GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB, Weichselbaum RR, Ishizaki K, Yandell DW (1992): Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res 52:6194-6199.
35. Vande Woude GF, Schulz N, Zhou R, Paules RS, Daarl, Yew N, Oskarsson M (1990): Cell cycle, oncogenes, and antineoplastic drugs. Accomplishments in Cancer Res 1:129-143.
36. Verma IM (1986): Proto-oncogene fos: A multifaceted gene. Trends Genet 2:93-96.
37. Wasson JC, Saylors III RL, Zelter P, Friedman HS, Bigner SH, Burger PC, Bignell DD, Look AT, Douglass EC, Brodeur GM (1990): Oncogene amplification in pediatric brain tumors. Cancer Res 50:2987-2990.
38. Weichselbaum RR, Beckett M, Diamond A (1988): Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. Proc Natl Acad Sci USA 85:2106-2109.
39. Wunder JS, Czitrom AA, Kandel R, Andrulis IL (1991): Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 83:194-200.